At Novartis, we’re committed to unraveling the inner workings of cancer. We’re developing new therapies for a range of common and rare cancers, investing in diverse technology platforms and experimenting with combination approaches.

Reimagining medicine in cancer

We have the passion and the people to help transform lives as we pursue treatments for patients.

Our disease areas

At Novartis, we push the limits of science to develop innovative therapies. These therapies have the potential to be new foundations for cancer care in areas with great unmet need.

Doctor examining rwandan patient

Breast cancer

Novartis is committed to driving measurable change by addressing disparities in breast cancer care. Our priority over the past 30 years and today is to deliver targeted therapies to potentially improve quality of life and extend lives for those diagnosed with breast cancer as we work towards a cure.

Doctor testing blood pressure

Hematology

From targeted therapies, to precision cell and gene therapy and immunotherapy – we have been pioneers in hematology, staying on the cutting edge in order to tackle blood cancers and serious blood disorders. Our research continues in new and different ways to harness the power of immunotherapy and potentially benefit a broader patient population than ever before. We are changing the hematological paradigm, transforming what it means to live with blood cancer or a serious blood disorder.